Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024
Compare Balance Sheet Results of Jagsonpal Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.28
10.38
2.90
27.94%
Share Warrants & Outstandings
Total Reserve
204.71
255.47
-50.76
-19.87%
Shareholder's Funds
239.95
265.84
-25.89
-9.74%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
15.12
-15.12
-100.00%
Secured Loans
0.00
15.12
-15.12
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
3.07
-1.61
4.68
290.68%
Other Long Term Liabilities
8.30
0.00
8.30
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.04
0.25
0.79
316.00%
Total Non-Current Liabilities
12.41
13.76
-1.35
-9.81%
Current Liabilities
Trade Payables
9.73
55.79
-46.06
-82.56%
Other Current Liabilities
15.16
16.22
-1.06
-6.54%
Short Term Borrowings
0.00
97.33
-97.33
-100.00%
Short Term Provisions
1.01
0.16
0.85
531.25%
Total Current Liabilities
25.90
169.51
-143.61
-84.72%
Total Liabilities
278.26
449.11
-170.85
-38.04%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
93.47
229.75
-136.28
-59.32%
Less: Accumulated Depreciation
7.25
85.29
-78.04
-91.50%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
86.23
144.47
-58.24
-40.31%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
3.55
-3.55
-100.00%
Long Term Loans & Advances
1.33
11.53
-10.20
-88.46%
Other Non Current Assets
21.29
4.66
16.63
356.87%
Total Non-Current Assets
117.07
164.20
-47.13
-28.70%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
15.20
83.47
-68.27
-81.79%
Sundry Debtors
13.18
155.90
-142.72
-91.55%
Cash and Bank
128.73
14.29
114.44
800.84%
Other Current Assets
1.66
12.79
-11.13
-87.02%
Short Term Loans and Advances
2.42
18.46
-16.04
-86.89%
Total Current Assets
161.19
284.90
-123.71
-43.42%
Net Current Assets (Including Current Investments)
135.29
115.40
19.89
17.24%
Total Current Assets Excluding Current Investments
161.19
284.90
-123.71
-43.42%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
278.26
449.11
-170.85
-38.04%
Contingent Liabilities
16.17
36.98
-20.81
-56.27%
Total Debt
0.00
112.45
-112.45
-100.00%
Book Value per share (adjusted)
36.08
255.44
-219.36
-85.88%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 8.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 86.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Current Assets
Current Assets 161.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024






